Evidence map›Paper›PMID 37702483›Full record

Observational studyAntimicrobial agents and chemotherapy2023

Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing

Kayoko Hayakawa, Yasufumi Matsumura, Kohei Uemura, Shinya Tsuzuki, Aki Sakurai, Ryutaro Tanizaki, Koh Shinohara, Takehiro Hashimoto, Ryota Hase, Takashi Matono and 7 more

Open access · greenAbstract readMulticenter StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Antimicrobial agents and chemotherapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 12 institutions in 3 countries.

Kayoko HayakawaDisease Control and Prevention Center, National Center for Global Health and Medicine , Tokyo, Japan.ORCID 0000-0002-5480-4405
Yasufumi MatsumuraDepartment of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine , Kyoto, Japan.ORCID 0000-0001-8595-8944
Kohei UemuraInterfaculty Initiative in Information Studies, The University of Tokyo , Tokyo, Japan.
Shinya TsuzukiDisease Control and Prevention Center, National Center for Global Health and Medicine , Tokyo, Japan.
Aki SakuraiDepartments of Microbiology and Infectious Diseases, Fujita Health University School of Medicine , Aichi, Japan.
Ryutaro TanizakiDepartment of Internal Medicine and General Medicine, Ise Municipal General Hospital , Mie, Japan.
Koh ShinoharaDepartment of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine , Kyoto, Japan.ORCID 0000-0001-8934-0375
Takehiro HashimotoInfection Control Center, Oita University Hospital , Oita, Japan.
Ryota HaseDepartment of Infectious Diseases, Japanese Red Cross Narita Hospital , Chiba, Japan.
Takashi MatonoDepartment of Infectious Diseases, Aso Iizuka Hospital , Fukuoka, Japan.
Hideaki KatoInfection Prevention and Control Department, Yokohama City University Hospital , Kanagawa, Japan.ORCID 0000-0002-7853-5721
Momoko MawatariDepartment of Infectious Diseases, Japanese Red Cross Medical Center , Tokyo, Japan.
Hiroshi HaraDepartment of pharmacy, Yokohama Brain and Spine Center , Kanagawa, Japan.
Yukihiro HamadaDepartment of pharmacy, Tokyo Women's Medical University Hospital , Tokyo, Japan.
Sho SaitoDisease Control and Prevention Center, National Center for Global Health and Medicine , Tokyo, Japan.
Norio OhmagariDisease Control and Prevention Center, National Center for Global Health and Medicine , Tokyo, Japan.
Yohei DoiDepartments of Microbiology and Infectious Diseases, Fujita Health University School of Medicine , Aichi, Japan.
National Center for Global Health and Medicine · JPFujita Health University · JPKyoto University · JPAso Iizuka Hospital · JPJapanese Red Cross Medical Center · JPJapanese Red Cross Narita Hospital · JPOita University Hospital · JPOme Municipal General Hospital · JPThe University of Tokyo · JPTokyo Women's Medical University Hospital · JPUniversity of Antwerp · BEYokohama City University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cefmetazole is active against extended-spectrum β-lactamase-producing

Indexed as

Escherichia coli InfectionsUrinary Tract InfectionsAnti-Bacterial Agentsbeta-LactamasesCefmetazoleEscherichia coliHumansMeropenemAnti-Bacterial Agentsbeta-LactamasesCefmetazoleMeropenemantimicrobial resistancecarbapenemcephamycinE. coliurinary tract infection

Identifiers

PMID37702483
PMCPMC10583665
OpenAlexW4386704991

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.